We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Ocrelizumab
Australian Public Assessment Report
Device/Product Name
Ocrevus
Active ingredients
Ocrelizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-01580-1-1
Submission Type
New chemical (biological) entity
Decision
Approved